April 06, 2020
An Illinois federal judge has thrown out a proposed class action against Baxter International Inc. and Hospira Inc. after finding a group of direct buyers of intravenous saline solution again failed to back up allegations that the pharmaceutical companies conspired to manipulate the product's market price.
January 31, 2019
Baxter International Inc. said Thursday it is no longer the subject of a U.S. Department of Justice antitrust investigation into whether it conspired to fix the price of intravenous saline solution by using recalls to stage a shortage.
July 05, 2018
An Illinois federal judge on Thursday dismissed Baxter International Inc. and Hospira Inc. without prejudice from an Alabama health care provider's proposed antitrust class action alleging that they conspired to fix the price of intravenous saline solution by using recalls to stage a shortage, agreeing that the theory is "implausible."
February 22, 2017
Baxter International Inc. and Hospira Inc. have each asked an Illinois federal court to dismiss an Alabama health care provider’s proposed antitrust class action alleging they conspired to fix the price of intravenous saline solution by using recalls to stage a shortage, with the former calling the allegations “pure fantasy.”
November 04, 2016
A health care provider in Alabama has sued pharmaceutical company Baxter International Inc. in Illinois federal court, alleging that Baxter and Hospira Inc. conspired to artificially raise prices of saline solution under the guise of a supply shortage in the U.S.